Food and drug manufacturers’ inspection records and citations for misleading advertising will be disclosed by U.S. regulators as part of the Obama administration’s efforts to improve transparency in government.
The Food and Drug Administration released a database of inspections conducted from Oct. 1, 2008, to Sept. 30, 2010, and plans to update the list each fiscal year, according to Tamara Ward, an agency spokeswoman. The FDA will also start sharing more letters warning companies of illegal product promotions within the next six to nine months, she said.
The new database includes the name and address of the company being inspected, the purpose of the visit, the date the review ended and whether the findings prompted additional actions or referral to state or FDA officials.
A New Database from the FDA: Inspections of Drug Manufacturing Facilities
Filed by May 31, 2011on